XML 97 R46.htm IDEA: XBRL DOCUMENT v3.25.0.1
Share Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Awards
The following table presents a summary of the Company’s unvested restricted stock awards:
Number of
Shares
Weighted-
Average Grant
Date Fair Value
(In thousands)
Unvested restricted shares outstanding at January 1, 2022
57 $5.26 
Granted18 $18.93 
Vested(57)$5.26 
Forfeited / Canceled— $— 
Unvested restricted shares outstanding at December 31, 2022
18 $18.93 
Granted54 $13.85 
Vested(18)$18.93 
Forfeited / Canceled— $— 
Unvested restricted shares outstanding at December 31, 2023
54 $13.85 
Granted65 $13.20 
Vested (1)(65)$13.76 
Forfeited / Canceled— $— 
Unvested restricted shares outstanding at December 31, 2024
53 $13.17 
Totals may not sum or recalculate due to rounding
____________________
(1)     The aggregate intrinsic value of restricted stock that vested during 2024 was approximately $0.9 million based on the stock price at the time of vesting.
The following table presents a summary of the Company’s unvested restricted stock units:
Number of
Units
Weighted-
Average Grant
Date Fair Value
(In thousands)
Unvested restricted stock units outstanding at January 1, 2022
406 $4.18 
Granted39 $13.51 
Vested(175)$3.61 
Forfeited / Canceled(18)$5.51 
Unvested restricted stock units outstanding at December 31, 2022
252 $5.93 
Granted79 $15.13 
Vested(175)$4.33 
Forfeited / Canceled(18)$11.50 
Unvested restricted stock units outstanding at December 31, 2023
138 $12.51 
Granted96 $13.14 
Vested (1)(81)$10.85 
Forfeited / Canceled— $— 
Unvested restricted stock units outstanding at December 31, 2024
153 $13.78 
Totals may not sum or recalculate due to rounding
____________________
(1)     The aggregate intrinsic value of restricted stock units that vested during 2024 was approximately $1.1 million based on the stock price at the time of vesting.
The following table presents a summary of the Company's performance share units:
Number of
Units
Weighted-
Average Grant
Date Fair Value
(In thousands)
Unvested performance share units outstanding at January 1, 2022
34 $5.01 
Granted19 $13.51 
Vested(34)$5.01 
Forfeited / Canceled(2)$13.51 
Unvested performance share units outstanding at December 31, 2022
17 $13.51 
Granted19 $15.31 
Vested(17)$13.51 
Forfeited / Canceled(3)$15.31 
Unvested performance share units outstanding at December 31, 2023
16 $15.31 
Granted23 $13.63 
Vested (1)(16)$15.31 
Forfeited / Canceled— $— 
Unvested performance share units outstanding at December 31, 2024
23 $13.63 
Totals may not sum or recalculate due to rounding
____________________
(1)     The aggregate intrinsic value of performance share units that vested during 2024 was approximately $0.2 million.
Schedule of Weighted Average Assumptions
The fair value of stock options was estimated on the date of the grant using a Black-Scholes valuation model that used the weighted average assumptions noted in the following table. Expected volatility is based on historical volatility of the Company’s common stock and other factors. The Company uses historical data on the exercise of stock options, post-vesting forfeitures and other factors to estimate the expected term of the stock-based payments granted. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant. Generally, stock options granted to employees and directors vest ratably over three years from the grant date and expire seven years from the date of grant. There were no stock options granted during the years ended December 31, 2024, 2023 or 2022.

AssumptionsFor the Year Ended December 31, 2021
Risk-free interest rate0.79 %
Expected dividend yield— %
Expected volatility78.2 %
Expected term5 years
Schedule of Stock Option Activity The following table presents a summary of the Company's stock option activity for the years ended December 31, 2024, 2023 and 2022:
Number of SharesWeighted Average Exercise Price per ShareWeighted Average Remaining Contractual Term(years)Aggregate Intrinsic Value (in millions)
(In thousands)
Outstanding at January 1, 2022
324 $— 7.80$0.80 
Granted— — — — 
Exercised(31)$17.53 — — 
Expired— — — — 
Forfeited / Canceled(7)— — — 
Outstanding at December 31, 2022
286 $— 7.64$2.38 
Exercisable at December 31, 2022
68 $— 6.49$0.64 
Outstanding at December 31, 2022
286 $— 7.64$2.38 
Granted— — — — 
Exercised(36)$15.68 — — 
Expired— — — — 
Forfeited / Canceled— — — — 
Outstanding at December 31, 2023
250 $— 7.66$1.02 
Exercisable at December 31, 2023
100 $— 7.66$0.41 
Outstanding at December 31, 2023
250 $— 7.66$1.02 
Granted— — — — 
Exercised— $— — — 
Expired— — — — 
Forfeited / Canceled— — — — 
Outstanding at December 31, 2024 (1)
250 $— 6.65$0.53 
Exercisable at December 31, 2024
150 $— 6.65$0.32 
Totals may not sum or recalculate due to rounding
____________________
(1)     All outstanding stock options as of December 31, 2024 are expected to vest.
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan
The following tables summarize the Company's share and incentive-based compensation for the years ended December 31, 2024, 2023 and 2022 (in thousands):
Recurring Compensation Expense (1)
Year Ended December 31, 2024
Equity-classified awards:
Restricted stock awards and units$1,790 
Performance share units264 
Stock options300 
Total share-based compensation expense$2,354 
Year Ended December 31, 2023
Equity-classified awards:
Restricted stock awards and units$1,415 
Performance share units229 
Stock options301 
Total share-based compensation expense$1,945 
Year Ended December 31, 2022
Equity-classified awards:
Restricted stock awards and units$997 
Performance share units215 
Stock options314 
Total share-based compensation expense$1,526 
____________________
(1)Recorded in general and administrative expense in the accompanying consolidated statements of operations.